Published in PLoS One on March 24, 2014
Molecular Mechanism of Switching of TrkA/p75(NTR) Signaling in Monocrotophos Induced Neurotoxicity. Sci Rep (2015) 0.76
Curcumin revitalizes Amyloid beta (25-35)-induced and organophosphate pesticides pestered neurotoxicity in SH-SY5Y and IMR-32 cells via activation of APE1 and Nrf2. Metab Brain Dis (2017) 0.75
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics (2005) 34.83
The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J (1953) 13.87
Tricine-SDS-PAGE. Nat Protoc (2006) 7.89
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol (2009) 2.90
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem (2008) 2.24
Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci (2009) 1.85
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology (2003) 1.70
Enzymatic mechanisms of ethanol oxidation in the brain. Alcohol Clin Exp Res (2006) 1.59
CYP2E1-dependent toxicity and oxidative stress in HepG2 cells. Free Radic Biol Med (2001) 1.44
Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice. Drug Metab Dispos (2012) 1.43
CYP2E1: biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr Mol Med (2003) 1.38
Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol (2011) 1.38
Expression and function of cytochrome p450 in brain drug metabolism. Curr Drug Metab (2007) 1.36
ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem (2008) 1.32
Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6. Curr Drug Metab (2009) 1.29
Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Brain Res Dev Brain Res (2002) 1.29
Cytochrome P450 enzymes in the brain: emerging evidence of biological significance. Trends Pharmacol Sci (2011) 1.28
Genetic polymorphism and toxicology--with emphasis on cytochrome p450. Toxicol Sci (2010) 1.26
Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells. Drug Metab Dispos (2009) 1.25
Human CYP2E1 is regulated by miR-378. Biochem Pharmacol (2009) 1.25
Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art. Curr Drug Metab (2011) 1.14
Mammalian cytochromes P450--importance of tissue specificity. Biochim Biophys Acta (2006) 1.11
Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow. Epilepsia (2010) 1.10
Molecular mechanisms of pesticide-induced neurotoxicity: Relevance to Parkinson's disease. Chem Biol Interact (2010) 1.10
Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos (2009) 1.10
Assessment of the blood-brain barrier in CNS drug discovery. Neurobiol Dis (2009) 1.09
Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation. Expert Opin Drug Metab Toxicol (2010) 1.07
Caspase cascade regulated mitochondria mediated apoptosis in monocrotophos exposed PC12 cells. Chem Res Toxicol (2010) 1.05
Nicotine induces brain CYP enzymes: relevance to Parkinson's disease. J Neural Transm Suppl (2006) 1.04
Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals. Life Sci (2010) 1.04
Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain. Neurotoxicology (2007) 1.03
Regulation of cytochrome P450 by posttranslational modification. Drug Metab Rev (2005) 1.02
Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br J Pharmacol (2003) 1.02
The alcohol-inducible form of cytochrome P450 (CYP 2E1): role in toxicology and regulation of expression. Arch Pharm Res (2000) 1.02
The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev (2004) 1.01
CYP2E1 and risk of chemically mediated cancers. Expert Opin Drug Metab Toxicol (2010) 1.01
Monocrotophos induced apoptosis in PC12 cells: role of xenobiotic metabolizing cytochrome P450s. PLoS One (2011) 1.00
Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition. Neuropsychopharmacology (2008) 0.98
Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. Hum Genet (2009) 0.95
Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects. Neuropsychopharmacology (2010) 0.92
Cytochrome P450-mediated drug metabolism in the brain. J Psychiatry Neurosci (2013) 0.91
Apoptosis in HepG2 cells exposed to high glucose. Toxicol In Vitro (2009) 0.90
Long lasting effects of prenatal exposure to deltamethrin on cerebral and hepatic cytochrome P450s and behavioral activity in rat offspring. Eur J Pharmacol (2006) 0.90
Preferential expression of antioxidant response element mediated gene expression in astrocytes. J Neurochem (2001) 0.90
The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study. Eur J Pharmacol (2009) 0.89
Acute seizure activity promotes lipid peroxidation, increased nitrite levels and adaptive pathways against oxidative stress in the frontal cortex and striatum. Oxid Med Cell Longev (2010) 0.89
Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience (2003) 0.89
Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. J Neurochem (2004) 0.89
Molecular characterization of CYP2B6 substrates. Curr Drug Metab (2008) 0.88
Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism. Drug Metab Pharmacokinet (2010) 0.88
Expression and inducibility of cytochrome P450s (CYP1A1, 2B6, 2E1, 3A4) in human cord blood CD34(+) stem cell-derived differentiating neuronal cells. Toxicol Sci (2012) 0.86
Effect of pretreatment of cytochrome P450 (P450) modifiers on neurobehavioral toxicity induced by deltamethrin. Food Chem Toxicol (2003) 0.86
Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substantia nigra: a new metabolic pathway? Synapse (2001) 0.86
Differences in sensitivity of cultured rat brain neuronal and glial cytochrome P450 2E1 to ethanol. Life Sci (2006) 0.86
Brain metabolism of ethanol and alcoholism: an update. Curr Drug Metab (2007) 0.85
Single and concerted effects of benzo[a]pyrene and flavonoids on the AhR and Nrf2-pathway in the human colon carcinoma cell line Caco-2. Toxicol In Vitro (2011) 0.85
Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production. Synapse (2008) 0.85
Distribution and differential induction of CYP2E1 by ethanol and acetone in the mesocorticolimbic system of rat. Alcohol Alcohol (2008) 0.85
Possible function of astrocyte cytochrome P450 in control of xenobiotic phenytoin in the brain: in vitro studies on murine astrocyte primary cultures. Exp Neurol (2001) 0.83
Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer. Cancer Epidemiol Biomarkers Prev (2008) 0.83
Organo-phosphate induced delayed neuropathy: report of two cases. Neurol India (2004) 0.83
Impaired mitochondrial functions in organophosphate induced delayed neuropathy in rats. Cell Mol Neurobiol (2009) 0.82
Responsiveness of cerebral and hepatic cytochrome P450s in rat offspring prenatally exposed to lindane. Toxicol Appl Pharmacol (2008) 0.81
Astrogliopathy as a loss of astroglial protective function against glycoxidative stress under hyperglycemia. Rinsho Shinkeigaku (2012) 0.81
Cytochrome P450 1A isoenzymes in brain cells: Expression and inducibility in cultured rat brain neuronal and glial cells. Life Sci (2006) 0.80
[Astrocytic cytochromes p450: an enzyme subfamily critical for brain metabolism and neuroprotection]. Rev Neurol (Paris) (2004) 0.80
Cytochrome p450 and glutathione s-transferase mRNA expression in human fetal liver hematopoietic stem cells. Drug Metab Dispos (2006) 0.79
Role of adrenoceptor-linked signaling pathways in the regulation of CYP1A1 gene expression. Biochem Pharmacol (2005) 0.78
The effect of acute severe monocrotophos poisoning on inhibition, expression and activity of acetylcholinesterase in different rat brain regions. Neurotoxicology (2012) 0.78
Cytochrome P450-mediated metabolism in brain: functional roles and their implications. Expert Opin Drug Metab Toxicol (2013) 0.78
Differences in the expression and inducibility of cytochrome P450 2B isoenzymes in cultured rat brain neuronal and glial cells. Mol Cell Biochem (2007) 0.78
RNAi-based screening identifies kinases interfering with dioxin-mediated up-regulation of CYP1A1 activity. PLoS One (2011) 0.78
Intronic polymorphisms of cytochromes P450. Hum Genomics (2010) 0.77
A role for CYP in the drug-hormone crosstalk of the brain. Expert Opin Drug Metab Toxicol (2010) 0.77
In vitro effects of organophosphate pesticides on rat erythrocytes. Indian J Exp Biol (2004) 0.77
Optimized experimental design for the estimation of enzyme kinetic parameters: an experimental evaluation. Drug Metab Dispos (2012) 0.76
In vitro induction of cytotoxicity and DNA strand breaks in CHO cells exposed to cypermethrin, pendimethalin and dichlorvos. Toxicol In Vitro (2007) 0.76
Design, Synthesis, and Biological Evaluation of Novel 1,2,4-Trioxanes as Potential Antimalarial Agents. Arch Pharm (Weinheim) (2017) 0.75
Monocrotophos Induces the Expression of Xenobiotic Metabolizing Cytochrome P450s (CYP2C8 and CYP3A4) and Neurotoxicity in Human Brain Cells. Mol Neurobiol (2016) 0.75